FDA Inspection 1037093 — Vitalant

Vitalant — FEI 1034631

The FDA completed an inspection of Vitalant on Jan 9, 2018 in Memphis, TN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 9, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Memphis, TN (United States)

Citations

IDCFRDescription
1809321 CFR 630.10(g)(1)Proof Of Identity
4121 CFR 606.40(a)(1)Provide space for examination

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.